ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $980,000 | +2.4% | 7,230 | -3.3% | 0.07% | -1.4% |
| Q4 2020 | $957,000 | -10.4% | 7,478 | -21.2% | 0.07% | -32.7% |
| Q3 2020 | $1,068,000 | +8.9% | 9,495 | -7.8% | 0.10% | +19.5% |
| Q2 2020 | $981,000 | +30.6% | 10,300 | +23.2% | 0.09% | +67.3% |
| Q1 2020 | $751,000 | -4.1% | 8,359 | -53.5% | 0.05% | +205.9% |
| Q4 2018 | $783,000 | -60.6% | 17,988 | -48.3% | 0.02% | -48.5% |
| Q3 2018 | $1,989,000 | +69.0% | 34,760 | +43.2% | 0.03% | +73.7% |
| Q2 2018 | $1,177,000 | +51.3% | 24,266 | -20.4% | 0.02% | +58.3% |
| Q4 2016 | $778,000 | – | 30,481 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |